{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T19:18:58Z","timestamp":1774120738639,"version":"3.50.1"},"reference-count":51,"publisher":"The Royal Society","issue":"63","license":[{"start":{"date-parts":[[2011,4,20]],"date-time":"2011-04-20T00:00:00Z","timestamp":1303257600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/royalsociety.org\/journals\/ethics-policies\/data-sharing-mining\/"}],"content-domain":{"domain":["royalsocietypublishing.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2011,10,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Individuals living with HIV experience a much higher risk of progression from latent M. tuberculosis infection to active tuberculosis (TB) disease relative to individuals with intact immune systems. A several-month daily course of a single drug during latent infection (i.e. isoniazid preventive therapy (IPT)) has proved in clinical trials to substantially reduce an HIV-infected individual's risk of TB disease. As a result of these findings and ongoing studies, the World Health Organization has produced strong guidelines for implementing IPT on a community-wide scale for individuals with HIV at risk of TB disease. To date, there has been limited use of IPT at a community-wide level. In this paper, we present a new co-network model for HIV and TB co-epidemics to address questions about how the population-level impact of community-wide IPT may differ from the individual-level impact of IPT offered to selected individuals. In particular, we examine how the effect of clustering of contacts within high-TB incidence communities may affect the rates of re-infection with TB and how this clustering modifies the expected population-level effects of IPT. We find that populations with clustering of respiratory contacts experience aggregation of TB cases and high numbers of re-infection events. While, encouragingly, the overall population-level effects of community-wide IPT appear to be sustained regardless of network structure, we find that in populations where these contacts are highly clustered, there is dramatic heterogeneity in the impact of IPT: in some sub-regions of these populations, TB is nearly eliminated, while in others, repeated re-infection almost completely undermines the effect of IPT. Our findings imply that as IPT programmes are brought to scale, we should expect local heterogeneity of effectiveness as a result of the complex patterns of disease transmission within communities.<\/jats:p>","DOI":"10.1098\/rsif.2011.0160","type":"journal-article","created":{"date-parts":[[2011,4,20]],"date-time":"2011-04-20T05:13:29Z","timestamp":1303276409000},"page":"1510-1520","update-policy":"https:\/\/doi.org\/10.1098\/crossmark-policy","source":"Crossref","is-referenced-by-count":15,"title":["Modelling the performance of isoniazid preventive therapy for reducing tuberculosis in HIV endemic settings: the effects of network structure"],"prefix":"10.1098","volume":"8","author":[{"given":"H. L.","family":"Mills","sequence":"first","affiliation":[{"name":"1","department":["Bristol Centre for Complexity Sciences, University of Bristol, Bristol, UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Cohen","sequence":"additional","affiliation":[{"name":"3","department":["Center for Communicable Disease Dynamics, Department of Epidemiology, Harvard School of Public Health, MA, USA"]},{"name":"4","department":["Division of Global Health Equity, Brigham and Women's Hospital, Boston, MA, USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Colijn","sequence":"additional","affiliation":[{"name":"2","department":["Department of Engineering Mathematics, University of Bristol, Bristol, UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"175","published-online":{"date-parts":[[2011,4,20]]},"reference":[{"key":"2026010520332821300_RSIF20110160C1","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1001\/archinte.163.9.1009","article-title":"The growing burden of tuberculosis: global trends and interactions with the HIV epidemic","volume":"163","author":"Corbett,","year":"2003","journal-title":"Arch. Int. Med."},{"key":"2026010520332821300_RSIF20110160C2","article-title":"Report on the global AIDS epidemic, August 2008","author":"UNAIDS","year":"2008"},{"key":"2026010520332821300_RSIF20110160C3","article-title":"Global tuberculosis control: a short update to the 2009 report, March","author":"World Health Organization","year":"2009"},{"key":"2026010520332821300_RSIF20110160C4","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/980594","article-title":"Changing concepts of \u2018latent tuberculosis infection\u2019 in patients living with HIV infection","volume":"2011","author":"Lawn,","year":"2011","journal-title":"Clin. Dev. Immunol"},{"key":"2026010520332821300_RSIF20110160C5","article-title":"WHO Three I's Meeting, April 2008. Report of a joint WHO HIV\/AIDS and TB Department meeting","author":"World Health Organization","year":"2008","journal-title":"Geneva, Switzerland, 2\u20134 April 2008"},{"key":"2026010520332821300_RSIF20110160C6","article-title":"Isoniazid preventive therapy (IPT) for people living with HIV, Consensus statement of the Core Group of the TB\/HIV Working Group of the Stop TB Partnership","author":"World Health Organization","year":"2009"},{"key":"2026010520332821300_RSIF20110160C7","article-title":"Randomized, placebo-controlled trial of 6 vs 36 months isoniazid TB preventive therapy for HIV-infected adults in Botswana","author":"Samandari,","year":"2010","journal-title":"17th Conf. on Retroviruses and Opportunistic Infections; San Francisco, CA, USA, 16\u201319 February 2010, Abstract 104LB"},{"key":"2026010520332821300_RSIF20110160C8","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000171.pub3","article-title":"Treatment of latent tuberculosis infection in HIV infected persons","volume":"1","author":"Akolo,","year":"2010","journal-title":"Cochrane Database Syst. Rev."},{"key":"2026010520332821300_RSIF20110160C9","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.cd001363","article-title":"Isoniazid for preventing tuberculosis in non-HIV infected persons","volume":"1","author":"Smieja,","year":"1999","journal-title":"Cochrane Database Syst. Rev."},{"key":"2026010520332821300_RSIF20110160C10","doi-asserted-by":"publisher","first-page":"7042","DOI":"10.1073\/pnas.0600349103","article-title":"Beneficial and perverse effects of isoniazid preventive therapy for latent tuberculosis infection in HIV\u2013tuberculosis coinfected populations","volume":"103","author":"Cohen,","year":"2006","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2026010520332821300_RSIF20110160C11","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1287\/opre.1080.0571","article-title":"Controlling co-epidemics: analysis of HIV and tuberculosis infection dynamics","volume":"56","author":"Long,","year":"2008","journal-title":"Oper. Res."},{"key":"2026010520332821300_RSIF20110160C12","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1007\/s11538-009-9423-9","article-title":"Modeling HIV\/AIDS and tuberculosis coinfection","volume":"71","author":"Bhunu,","year":"2009","journal-title":"Bull. Math. Biol."},{"key":"2026010520332821300_RSIF20110160C13","doi-asserted-by":"publisher","first-page":"e74","DOI":"10.1371\/journal.pmed.0050074","article-title":"Social contacts and mixing patterns relevant to the spread of infectious diseases","volume":"5","author":"Mossong,","year":"2008","journal-title":"PLoS Med."},{"key":"2026010520332821300_RSIF20110160C14","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-9-5","article-title":"Mining social mixing patterns for infectious disease models based on a two-day population survey in Belgium","volume":"9","author":"Hens,","year":"2009","journal-title":"BMC Infect. Dis."},{"key":"2026010520332821300_RSIF20110160C15","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1098\/rsif.2005.0051","article-title":"Networks and epidemic models","volume":"2","author":"Keeling,","year":"2005","journal-title":"J. R. Soc. Interface"},{"key":"2026010520332821300_RSIF20110160C16","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1111\/j.1365-3156.2010.02533.x","article-title":"Spatial analysis of tuberculosis in an Urban West African setting: is there evidence of clustering?","volume":"15","author":"Touray,","year":"2010","journal-title":"Trop. Med. Int. Health"},{"key":"2026010520332821300_RSIF20110160C17","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1056\/NEJMoa1003176","article-title":"Whole-genome sequencing and social-network analysis of a tuberculosis outbreak","volume":"364","author":"Gardy,","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"2026010520332821300_RSIF20110160C18","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1098\/rspb.2002.2305","article-title":"Disease evolution on networks: the role of contact structure","volume":"270","author":"Read,","year":"2003","journal-title":"Proc. R. Soc. Lond. B"},{"key":"2026010520332821300_RSIF20110160C19","doi-asserted-by":"publisher","first-page":"016128","DOI":"10.1103\/PhysRevE.66.016128","article-title":"Spread of epidemic disease on networks","volume":"66","author":"Newman,","year":"2002","journal-title":"Phys. Rev. E"},{"key":"2026010520332821300_RSIF20110160C20","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1038\/35082140","article-title":"The web of human sexual contacts","volume":"411","author":"Liljeros,","year":"2001","journal-title":"Nature"},{"key":"2026010520332821300_RSIF20110160C21","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1098\/rsif.2006.0193","article-title":"Exogenous re-infection and the dynamics of tuberculosis epidemics: local effects in a network model of transmission","volume":"4","author":"Cohen,","year":"2007","journal-title":"J. R. Soc. Interface"},{"key":"2026010520332821300_RSIF20110160C22","article-title":"AIDS epidemic update","author":"World Health Organization","year":"2009"},{"key":"2026010520332821300_RSIF20110160C23","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1017\/S0950268897007917","article-title":"The natural history of tuberculosis: the implications of age-dependent risks of disease and the role of reinfection","volume":"119","author":"Vynnycky,","year":"1997","journal-title":"Epidemiol. Infect."},{"key":"2026010520332821300_RSIF20110160C24","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0041-3879(71)90015-8","article-title":"Ten-year results during the introduction of chemotherapy for tuberculosis","volume":"52","author":"Springett,","year":"1971","journal-title":"Tubercle"},{"key":"2026010520332821300_RSIF20110160C25","first-page":"35","article-title":"The epidemiological basis of tuberculosis control","author":"Enarson,","year":"1998","journal-title":"Clinical tuberculosis"},{"key":"2026010520332821300_RSIF20110160C26","first-page":"1886","article-title":"Prospects for worldwide tuberculosis control under the WHO DOTS strategy","volume":"352","author":"Dye,","year":"1998","journal-title":"Lancet Infect. Dis."},{"key":"2026010520332821300_RSIF20110160C27","article-title":"WHO case definitions of HIV for surveillance and revised clinical staging and immunological classification of HIV-related disease in adults and children, August 2006","author":"World Health Organization","year":"2006"},{"key":"2026010520332821300_RSIF20110160C28","doi-asserted-by":"publisher","first-page":"255","DOI":"10.2307\/3212829","article-title":"The second-order analysis of stationary point processes","volume":"13","author":"Ripley,","year":"1976","journal-title":"J. Appl. Probab."},{"key":"2026010520332821300_RSIF20110160C29","doi-asserted-by":"publisher","first-page":"026121","DOI":"10.1103\/PhysRevE.68.026121","article-title":"Properties of highly clustered networks","volume":"68","author":"Newman,","year":"2003","journal-title":"Phys. Rev. E"},{"key":"2026010520332821300_RSIF20110160C30","first-page":"1796","article-title":"Ripley's K function","volume":"3","author":"Dixon,","year":"2002","journal-title":"Encycl. Environmetr."},{"key":"2026010520332821300_RSIF20110160C31","doi-asserted-by":"publisher","first-page":"253","DOI":"10.2471\/BLT.09.066522","article-title":"Implementation of co-trimoxazole prophylaxis and isoniazid preventive therapy for people living with HIV","volume":"88","author":"Date,","year":"2010","journal-title":"Bull. World Health Organ."},{"key":"2026010520332821300_RSIF20110160C32","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/QAI.0b013e3181c3cbf0","article-title":"Isoniazid tuberculosis preventive therapy in HIV-infected adults accessing antiretroviral therapy: a Botswana experience, 2004\u20132006","volume":"54","author":"Mosimaneotsile,","year":"2010","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"2026010520332821300_RSIF20110160C33","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/S1473-3099(09)70043-x","article-title":"Approaches to tuberculosis screening and diagnosis in people with HIV in resource-limited settings","volume":"9","author":"Reid,","year":"2009","journal-title":"Lancet Infect. Dis."},{"key":"2026010520332821300_RSIF20110160C34","article-title":"Guidelines for intensified tuberculosis case-finding and isoniazid preventive therapy for people living with HIV in resource-constrained settings, December","author":"World Health Organization","year":"2010"},{"key":"2026010520332821300_RSIF20110160C35","article-title":"Two studies, 2 conclusions about duration of TB prevention therapy for HIV-infected patients","author":"Boughton,","year":"2010","journal-title":"Medscape Medical News"},{"key":"2026010520332821300_RSIF20110160C36","article-title":"Efficacy of a 6-month vs a 36-month regimen for prevention of tuberculosis in HIV-infected persons in India: a randomized clinical trial","author":"Swaminathan,","year":"2010","journal-title":"17th Conf. on Retroviruses and Opportunistic Infections"},{"key":"2026010520332821300_RSIF20110160C37","doi-asserted-by":"publisher","first-page":"2968","DOI":"10.1001\/jama.283.22.2968","article-title":"Spread of Mycobacterium tuberculosis in a community implementing recommended elements of tuberculosis control","volume":"283","author":"Chin,","year":"2000","journal-title":"J. Am. Med. Assoc."},{"key":"2026010520332821300_RSIF20110160C38","first-page":"271","article-title":"Tuberculosis transmission patterns in a high-incidence area: a spatial analysis","volume":"7","author":"Munch,","year":"2003","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"2026010520332821300_RSIF20110160C39","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.tpb.2007.09.007","article-title":"Modelling disease spread through random and regular contacts in clustered populations","volume":"73","author":"KTD Eames","year":"2008","journal-title":"Theor. Popul. Biol."},{"key":"2026010520332821300_RSIF20110160C40","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1098\/rsif.2008.0524","article-title":"Spread of infectious disease through clustered populations","volume":"6","author":"Miller,","year":"2009","journal-title":"J. R. Soc. Interface"},{"key":"2026010520332821300_RSIF20110160C41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.tpb.2004.08.002","article-title":"The implications of network structure for epidemic dynamics","volume":"67","author":"Keeling,","year":"2005","journal-title":"Theor. Popul. Biol."},{"key":"2026010520332821300_RSIF20110160C42","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1000736","article-title":"Dynamics and control of diseases in networks with community structure","volume":"6","author":"Salath\u00e9,","year":"2010","journal-title":"PLoS Comput. Biol."},{"key":"2026010520332821300_RSIF20110160C43","doi-asserted-by":"publisher","first-page":"e50","DOI":"10.1371\/journal.pmed.0040050","article-title":"XDR-TB in South Africa: no time for denial or complacency","volume":"4","author":"Singh,","year":"2007","journal-title":"PLoS Med."},{"key":"2026010520332821300_RSIF20110160C44","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/nrmicro2048","article-title":"Doomsday postponed? Preventing and reversing epidemics of drug-resistant tuberculosis","volume":"7","author":"Dye,","year":"2009","journal-title":"Nat. Rev. Microbiol."},{"key":"2026010520332821300_RSIF20110160C45","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/S1473-3099(08)70260-3","article-title":"Extensively drug-resistant tuberculosis","volume":"9","author":"Jassal,","year":"2009","journal-title":"Lancet Infect. Dis."},{"key":"2026010520332821300_RSIF20110160C46","doi-asserted-by":"publisher","first-page":"16 302","DOI":"10.1073\/pnas.0808746105","article-title":"Modeling the effects of strain diversity and mechanisms of strain competition on the potential performance of new tuberculosis vaccines","volume":"105","author":"Cohen,","year":"2008","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2026010520332821300_RSIF20110160C47","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s11538-008-9361-y","article-title":"Latent coinfection and the maintenance of strain diversity","volume":"71","author":"Colijn,","year":"2009","journal-title":"Bull. Math. Biol."},{"key":"2026010520332821300_RSIF20110160C48","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1097\/00002030-200401020-00010","article-title":"Decline in HIV infectivity following the introduction of highly active antiretroviral therapy","volume":"18","author":"Porco,","year":"2004","journal-title":"AIDS"},{"key":"2026010520332821300_RSIF20110160C49","doi-asserted-by":"publisher","first-page":"1163\u20131169","DOI":"10.1097\/01.aids.0000226957.79847.d6","article-title":"Generic fixed-dose combination antiretroviral treatment in resource-poor settings: multicentric observational cohort","volume":"20","author":"Calmy,","year":"2006","journal-title":"AIDS"},{"key":"2026010520332821300_RSIF20110160C50","doi-asserted-by":"publisher","first-page":"S149","DOI":"10.1097\/01.aids.0000327636.82542.87","article-title":"Evaluating the impact of antiretroviral therapy on HIV transmission","volume":"22","author":"Salomon,","year":"2008","journal-title":"AIDS"},{"key":"2026010520332821300_RSIF20110160C51","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.1016\/S0140-6736(10)60705-2","article-title":"Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis","volume":"375","author":"Donnell,","year":"2010","journal-title":"Lancet Infect. Dis."}],"container-title":["Journal of The Royal Society Interface"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/royalsocietypublishing.org\/doi\/pdf\/10.1098\/rsif.2011.0160","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/royalsocietypublishing.org\/doi\/full-xml\/10.1098\/rsif.2011.0160","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/royalsocietypublishing.org\/rsif\/article-pdf\/8\/63\/1510\/499262\/rsif.2011.0160.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/royalsocietypublishing.org\/rsif\/article-pdf\/8\/63\/1510\/499262\/rsif.2011.0160.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T01:33:34Z","timestamp":1767663214000},"score":1,"resource":{"primary":{"URL":"https:\/\/royalsocietypublishing.org\/rsif\/article\/8\/63\/1510\/65776\/Modelling-the-performance-of-isoniazid-preventive"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4,20]]},"references-count":51,"journal-issue":{"issue":"63","published-print":{"date-parts":[[2011,10,7]]}},"URL":"https:\/\/doi.org\/10.1098\/rsif.2011.0160","relation":{},"ISSN":["1742-5689","1742-5662"],"issn-type":[{"value":"1742-5689","type":"print"},{"value":"1742-5662","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,4,20]]},"assertion":[{"value":"2011-03-22","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2011-03-30","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2011-04-20","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}